ClinicalTrials.Veeva

Menu

Melody PB1016 Surveillance Study

Medtronic logo

Medtronic

Status

Completed

Conditions

Dysfunctional RVOT Conduits in Patients With Congenital Heart Defects

Treatments

Device: Melody Transcatheter Pulmonary Valve PB1016

Study type

Interventional

Funder types

Industry

Identifiers

NCT02347189
10154745DOC

Details and patient eligibility

About

Non-randomized, multi-center, prospective surveillance study to investigate and assess the residual risks, and to confirm the currently established safety and performance of the Melody TPV PB1016.

Enrollment

39 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient eligible to receive Melody TPV PB1016 per current Instructions for Use (IFU) indications at time of study enrollment
  • Patient (or patient's legally authorized representative) is willing to consent to participate in the study and will commit to completion of all follow-up requirements.

Exclusion criteria

  • Implantation in the aortic, tricuspid, or mitral position
  • Venous anatomy unable to accommodate a 22-Fr size introducer sheath
  • Obstruction of the central veins
  • Clinical or biological signs of infection including active endocarditis
  • History of intravenous substance abuse
  • Currently participating in an investigational drug or device study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

39 participants in 1 patient group

Melody TPV PB1016
Other group
Treatment:
Device: Melody Transcatheter Pulmonary Valve PB1016

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems